BOLTON SECURITIES CORPORATION’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.59M Sell
22,727
-643
-3% -$75.7K 0.1% 218
2026
Q2
$2.49M Buy
23,370
+3,689
+19% +$447K 0.09% 232
2026
Q1
$3.22M Buy
19,681
+271
+1% +$41.7K 0.15% 146
2025
Q4
$3.38M Buy
19,410
+203
+1% +$37K 0.16% 145
2025
Q3
$2.77M Buy
19,207
+1,858
+11% +$228K 0.13% 191
2025
Q2
$1.75M Buy
17,349
+12,043
+227% +$921K 0.09% 239
2025
Q1
$405K Buy
+5,306
New +$406K 0.02% 528

Other funds holding INSM

BOLTON SECURITIES CORPORATION's INSM Position: Q3 2026 in Review

BOLTON SECURITIES CORPORATION reduced its Insmed (INSM) stake by 2.8% in Q3 2026, selling an estimated $75.7K and leaving 22,727 shares worth $2.59M. The position accounts for 0.1% of the portfolio, ranked #218.

BOLTON SECURITIES CORPORATION first reported a position in INSM in Q1 2025 and has held it in 7 quarters since. The position peaked at $3.38M in Q4 2025. 547 funds tracked by Wall St. Rank hold INSM as of Q3 2026.

  • BOLTON SECURITIES CORPORATION held 22,727 shares of Insmed worth $2.59M as of Q3 2026.
  • BOLTON SECURITIES CORPORATION sold 643 Insmed shares in Q3 2026, an estimated $75.7K.
  • Insmed made up 0.1% of BOLTON SECURITIES CORPORATION's portfolio in Q3 2026, its #218 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in Insmed in Q1 2025 and has held it in 7 quarters since.
  • BOLTON SECURITIES CORPORATION's Insmed position peaked at $3.38M in Q4 2025.
  • 547 funds tracked by Wall St. Rank held Insmed as of Q3 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q3 2026, filed 12 Nov 2026.